Improving Access to Medicines – expansion of the Continuous Glucose Monitoring program
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
The Government will expand eligibility of the Continuous Glucose Monitoring (CGM) program to include people under 21 years of age with congenital hyperinsulinaemia. Free access to CGM monitoring devices will help this high need group to better manage this difficult disease and further support their families and carers.